New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 15, 2012
05:13 EDTSBUX, NLY, GLD, DNDN, HD, EXC, SIRI, BAC, ZIP, ZNGA, CL, PM, PCAR, CMI, AMRC, AGNC, LOW, DECK, WFMI, PCLN, MSFT, IBM, VVUS, ACAT, HSTM, REGN, QCOR, GS, YHOO, AAPL, KO, PCYC, PFE, JPM, MDVN, IDIX, CONN, MNST, SXCIJim Cramer's "Mad Money"
Wednesday was Jim Cramer's anniversary of his "Mad Money" TV show. He said it's time to come off the sidelines, sell those bank CDs earning 0.4% interest and invest in great American companies. Cramer said today's markets are being driven by pure growth, U.S. growth. He said everything from health care to retail to technology, even the homebuilders, are just beginning to show sustainable recoveries. Stocks like JPMorgan Chase (JPM) and IBM (IBM), are both leading the charge. Then there's Apple (AAPL) Cramer said while some investors can't fathom Apple's historic rise, he remembers a time when Coca-Cola (KO) and Pfizer (PFE) were the most valued companies on Wall Street. Apple is so much more than just a technology company, he said, adding it's a communications, education and entertainment company as well, all of which makes it worth its valuation. Cramers said the markets can most certainly take out its recent highs and march into bull-market mode, with a pickup in commercial construction and improved job growth looming just around the corner. Cramer recapped his "Magnificent Seven" speculative stocks to show viewers just how lucrative this under-rated method of investing can be. He said that every investor should have one spot in their portfolio dedicated to a speculative stock that adds excitement to their holdings. Cramer's magnificent seven stocks included Pharmacyclics (PCYC), a stock up 393% over the past 12 months, Medivation (MDVN), a biotech up 320%, Idenix Pharmaceuticals (IDIX), up 277%, and Vivus (VVUS), up 224%. Rounding out the seven were Arctic Cat (ACAT), which has risen 204% in 12 months, Conn's (CONN), up 211% and HealthStream (HSTM), which is up 192%. Next, Cramer also highlighted the seven best stocks that he's recommended since "Mad Money" first aired back in 2005, a list that exemplifies what "staying in the game" is all about. His top seven recommendations included Monster Beverage (MNST), which has risen 1,600% over the past seven years, the biotech company Regeneron (REGN), up 1,700% over seven years and Medivation (MDVN), the only company to make both of Cramer's lists, up 1,800%. The list also included Green Mountain Coffee Roasters (GMCR), a stock that despite huge losses recently, is still up 2,700% over seven years, SXC Health Solutions (SXCI) up 2800%, travel site Priceline.com (PCLN), up 2,850% and finally, Questcor Pharmceuticals (QCOR), which has rallied an astounding 7,066% over seven years. Cramer said when companies are riding long-term trends, their successes can turn into huge gains for shareholders. Next, Cramer responded to a New York Times op-ed piece chastising Goldman Sachs (GS), saying that the company often put its own interests ahead of those of its clients. Cramer said he didn't see any of this type of behavior when he worked for Goldman years ago. He said while he's sure that many of Goldman's employees are still committed to doing right by clients, perhaps this article can serve as a wake-up call for the firm to do even better for its clients, even if that means being less profitable in the short term. MAD TWEETS: Cramer said that Microsoft (MSFT) was a good stock, Yahoo (YHOO) was a bad one and Sirius XM Radio (SIRI) was a speculative one. Deckers Outdoor (DECK), said the warm winter hit this cold-weather shoemaker hard. Cramer was bullish on Starbucks (SBUX). Restructuring is working at Lowes (LOW) but he still prefers Home Depot (HD), and with gold stocks still suffering, he still likes the SPDR Gold Shares (GLD). Finally when asked about ZipCar (ZIP), Cramer said if investors want to invest in a recent IPO, he'd go with mobile game maker Zynga (ZNGA). LIGHTNING ROUND: (Bullish) ECL;PM; PCAR; CMI; AGNC; NLY; AMRC; EXC; WFMI. (Bearish) DNDN; BAC. Reference Link
News For DECK;SIRI;NLY;AGNC;YHOO;MSFT;CMI;GS;PCLN;PCAR;QCOR;SXCI;PM;REGN;MNST;CL;HSTM;CONN;ZNGA;ACAT;IDIX;ZIP;VVUS;MDVN;BAC;HD;JPM;PCYC;DNDN;PFE;KO;GLD;WFMI;AAPL;IBM;LOW;EXC;SBUX;AMRC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | all recent news | >>
June 24, 2015
10:00 EDTGSOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Autoliv (ALV) downgraded to Sell from Neutral at Goldman... Catamaran (CTRX) downgraded to Neutral from Buy at UBS... Citi (C) downgraded to Hold from Buy at Deutsche Bank... Esperion (ESPR) downgraded to Neutral from Outperform at Credit Suisse... Fortinet (FTNT) downgraded to Neutral from Buy at Citi... General Motors (GM) downgraded to Neutral from Buy at Goldman... Goldman Sachs (GS) downgraded to Hold from Buy at Deutsche Bank... IBERIABANK (IBKC) downgraded to Neutral from Outperform at Baird... Independent Bank (INDB) downgraded to Underperform from Neutral at Baird... Inphi (IPHI) downgraded to Market Perform from Outperform at Northland... MoneyGram (MGI) downgraded to Neutral from Outperform at Macquarie... Sensata (ST) downgraded to Hold from Buy at Cross Research... Teradyne (TER) downgraded to Buy from Conviction Buy at Goldman... Alcobra (ADHD) downgraded to Hold from Speculative Buy at WBB Securities.
09:48 EDTAAPLApple reaches royalty deal with Beggars Group
Subscribe for More Information
09:37 EDTAAPLReport: Apple may adopt flexible OLED displays in 2018, DigiTimes says
Subscribe for More Information
09:35 EDTAAPL, SBUX, MSFTActive equity options trading on open
Subscribe for More Information
09:30 EDTAAPLGoogle competing with itself after unveiling free music service, Bloomberg says
Subscribe for More Information
09:18 EDTAAPLApple June quarter iPhone demand strong, says Morgan Stanley
Morgan Stanley's AlphaWise survey indicates 53M iPhone unit demand for the June quarter, unchanged from last month's reading. The firm adds that Apple Watch demand has sustained healthy levls after the initial spike and investor expectations for iPhone and Watch growth are low. Morgan Stanley rates Apple an Overweight with a $166 price target.
09:10 EDTIBMOn The Fly: Pre-market Movers
Subscribe for More Information
09:07 EDTPFECAR-T cancer drug researchers seen as M&A targets, Bloomberg says
Juno Therapeutics (JUNO), Kite Pharma (KITE) and Bluebird Bio (BLUE) are trading well above their IPO levels as takeovers predictions have spurred interest and share increases for the developers of CAR-T gene therapies, said Bloomberg's "Real M&A" column, quoting Dimo Dimov, a professor at the University of Bath’s School of Management, as having said that companies such as Pfizer (PFE), Merck (MRK), Roche (RHHBY) and AstraZeneca (AZN) are "closely watching" the firms. Cellectis (CLLS), which is working with Pfizer on its own approach to CAR-T therapy, has said it wants to bring its therapy to market and doesn’t anticipate a sale, the report noted. Reference Link
09:01 EDTSBUXAerohive names Starbucks CIO Curt Garner to board of directors
Subscribe for More Information
08:57 EDTJPMJPMorgan price target raised to $77 from $70 at Argus
Argus increased its price target on JPMorgan based on the bank's cost cutting efforts and expectations for rising interest rates., along with what Argus sees as moderating concerns over litigation expenses and a good investment banking/trading environment. The firm expects the stock's multiple to increase, and it reiterates a Buy rating.
07:45 EDTAAPLSharp asking suppliers to cut prices for LCD parts, WSJ says
Subscribe for More Information
07:28 EDTAMRCRoth Capital to hold a conference
ROTH Cleantech Day is being held in London, England on June 24-25.
07:19 EDTJPMJPMorgan names Nachimowski head of chemicals dealmaking in EMEA, Bloomberg says
Subscribe for More Information
06:37 EDTGS, JPM, BACDeutsche downgrades Citi, Goldman after share rallies
Deutsche Bank analyst Matt O'Connor recommends using the strong share performance of both Citi (C) and Goldman Sachs (GS) as on opportunity to take profits. The analyst this morning downgraded shares of both investment banks to Hold from Buy. Citi is up 21% from the lows on January 30 while Goldman is up 30% since July 1, 2014, the analyst points out. On Citi, O'Connor sees less near term upside with fixed income trading entering a seasonally weak period and core cost reductions largely over. On Goldman, the analyst sees a lack of catalysts to drive the stock meaningfully higher in the near term. His top picks among U.S. Banks are Bank of America (BAC), JPMorgan (JPM), M&T Bank (MTB) and SunTrust (STI).
06:27 EDTGSGoldman Sachs downgraded to Hold from Buy at Deutsche Bank
Subscribe for More Information
06:12 EDTAAPLiPhone 6 resale value suggests strong demand, says Piper Jaffray
Subscribe for More Information
06:07 EDTMSFTJefferies says PC market to stay 'lower for longer'
Subscribe for More Information
06:00 EDTAAPLGoogle held 29 high-level meetings in Brussels in 6 months, Financial Times says
Subscribe for More Information
05:53 EDTGLDSPDR Gold Trust 30-day implied volatility at 13, 52-week range 12 to 24
05:10 EDTIBMIBM, Box announce global partnership
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use